Summary:
Learn how a novel parallel screening technology can evaluate the potential of peptides and macromolecules for oral delivery against two biological barriers simultaneously: the duodenal and sublingual barriers. The animal PK data in each phase was used to select the promising formulations for further development to achieve the optimal oral bioavailability.